hospitalization, and death. (Lack of resources)
Nirmatrelvir : severe acute respiratory syndrome coronavirus 2 main protease (Mpro) inhibitor with potent pan–human-coronavirus activity in vitro.
Ritonavir low dose 100mg (CYP3A inhibitor) : Enhancing nirmatrelvir pharmacokinetics (approximately five to six times in vitro 90% effective concentration of nirmatrelvir)
antiviral era
1996 : antiviral therapy actually began
-> much better response as the times go by.
Only about 25% of those in need of treatment currently receive it in the developing world.
Less than half of infected persons are eligible for treatment based on current guidelines(only eligible at advanced stages of diseases)
Treatment must be administered for lifetime and does not cure i
antiviral drugs and others. Its consumer products consist of hair dyes, antidepilatory agents, ladies cleanser, wound pastes, condoms and oral care products such as mouthwash and toothpastes. Its functional food includes nutrition such as vitamin C powder and healthcare drinks. The Company distributes medicines, which are developed by the Company itself, to overseas markets such as Southeast Asia